Utilizing advanced biotechnology, our engineered bispecific antibodies bind two distinct targets. This innovation has the potential to revolutionize therapeutic strategies, heightening specificity, expanding treatment options, and paving the way for future medical advancements.
F2 Building, Yizhuang Biomedical Park, No. 88, Kechuang Six Street, Beijing. P.R. China. 101111.
© 2023 Kyinno Biotechnology | Site Credits | Privacy Policy | Accessibility Policy | Sitemap